Pharma & Biotech

Viking Therapeutics finds itself at a pivotal juncture, navigating a complex landscape with a portfolio of promising metabolic disease treatments....

Eli Lilly has secured a significant regulatory milestone from the U.S. Food and Drug Administration. The agency granted Breakthrough Therapy...

ResMed, a global leader in sleep medicine technology, finds itself at a fascinating crossroads. The company is making ambitious strategic...

Glaukos Corporation reported exceptional financial results for its second quarter, yet its stock experienced notable selling pressure in subsequent trading....

In a competitive genomics market, Pacific Biosciences has unveiled a significant strategic move through a new collaboration with EpiCypher. This...

In a strategic move to strengthen its commercial capabilities, proteomics technology company Seer has appointed financial and life sciences expert...

Iovance Biotherapeutics shares are confronting significant pressure from three distinct fronts as the company prepares to present at today's Wells...

The pharmaceutical sector is closely monitoring the impending acquisition of Verona Pharma by industry giant Merck & Co., a transaction...

Tango Therapeutics faced significant selling pressure as investors reacted to disappointing second-quarter 2025 financial results. The biotechnology company reported both...

Shares of CEL-SSCI experienced a notable decline of 4.99% in Tuesday's trading session, closing at $11.24. The stock demonstrated significant...